Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-11-007812
Filing Date
2011-12-12
Accepted
2011-12-12 16:31:14
Documents
11
Period of Report
2011-10-31

Document Format Files

Seq Description Document Type Size
1 c67769_10-q.htm 10-Q 542324
2 c67769_ex31-1.htm EX-31.1 9155
3 c67769_ex31-2.htm EX-31.2 9117
4 c67769_ex32-1.htm EX-32.1 3099
5 c67769_ex32-2.htm EX-32.2 3090
  Complete submission text file 0000930413-11-007812.txt   3136341

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE enz-20111031.xml EX-101.INS 611187
7 enz-20111031.xsd EX-101.SCH 18825
8 XBRL CALCULATION FILE enz-20111031_cal.xml EX-101.CAL 29525
9 XBRL DEFINITION FILE enz-20111031_def.xml EX-101.DEF 86218
10 XBRL LABEL FILE enz-20111031_lab.xml EX-101.LAB 128673
11 XBRL PRESENTATION FILE enz-20111031_pre.xml EX-101.PRE 99785
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 111256438
SIC: 8071 Services-Medical Laboratories